Physician profile
Collyn A Steele
NPI 1649445883
$1,863.54
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,129 · 2020: $516 · 2021: $219.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $502.29 | 2019-2021 | |
| Astellas Pharma US INC | $406.10 | 2019-2021 | |
| Medtronic USA, INC. | $128.56 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.23 | 2019-2020 | |
| Boston Scientific Corporation | $106.29 | 2020 | |
| Abbvie INC. | $76.89 | 2019-2021 | |
| Phadia US INC. | $71.20 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $62.68 | 2019-2020 | |
| Novo Nordisk INC | $54.88 | 2019-2020 | |
| Lilly USA, LLC | $52.79 | 2019-2021 | |
| Pfizer INC. | $49.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $45.24 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $36.90 | 2020 | |
| Novartis Pharmaceuticals Corporation | $32.45 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $26.31 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $19.80 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.34 | 2020 | |
| Corcept Therapeutics | $15.11 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.69 | 2019 | |
| Glaxosmithkline, LLC. | $12.66 | 2019 | |
| Ironwood Pharmaceuticals, INC | $11.40 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $10.97 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collyn Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.